MT2019-37: A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 -Antitrypsin (AAT) Combined with Corticosteroids vsCorticosteroids Alone for the Treatment of High Risk Acute Graft-versus-HostDisea

Project: Research project

Project Details

Description

MT2019-37: A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 - Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disea
StatusActive
Effective start/end date10/1/1910/31/24

Funding

  • National Marrow Donor Program

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.